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Summary
Objective: In normal articular cartilage cells, the IGFRI/insulin-like growth factor 1 (IGF-1) autocrine pathway was shown to overrule the
catabolic effects of the IL-1/IL-1RI pathway by up-regulation of the IL-1RII decoy receptor. The activity of the IGF-1/IGFR1 and IL-1/IL-1R
pathways, and of the IL-1RII control mechanism in the synthesis and turnover of the extracellular matrix (ECM) by chondrocytes from normal
and osteoarthritic (OA) articular cartilage was compared in order to identify possible therapeutic targets of this disease.
Methods: Phenotypically stable human articular cartilage cells were obtained from normal and OA cartilage of the same knee showing focal
OA. The cells were cultured in alginate beads over 1 week to re-establish the intracellular cytokine and growth factors, to reexpress the
respective plasma membrane receptors and to reach equilibrium in accumulated cell-associated matrix (CAM) compounds. Following
liberation of the cells from the alginate beads, the levels of cell-associated matrix (CAM) aggrecan, type II collagen and fibronectin, of
intracellular IGF-1, IL-1 and  and of their respective plasma membrane-bound receptors, IGFR1, IL-1RI and the decoy receptor IL-1RII,
were assayed using flow cytometry.
Results: Coordinated production and accumulation of CAM aggrecan and type II collagen under the effect of the IGFR1/IGF-1 autocrine
pathway—as documented for chondrocytes from healthy controls—was absent when the chondrocytes had been obtained from OA joints.
When compared with cells obtained from normal tissues, chondrocytes from fibrillated OA cartilage expressed significantly higher
intracellular IGF-1 levels and plasma membrane-bound IGFR1. At the same time, significantly higher intracellular IL-1 and  levels and
upregulated plasma membrane-bound IL-1RI were observed. Plasma membrane-bound IL-1RII decoy receptor was downregulated in OA
chondrocytes. The levels of CAM aggrecan, type II collagen and fibronectin were significantly reduced in the chondrocytes obtained from
pathological tissue.
Conclusion: Paired analysis of normal and OA chondrocytes from the same knee joint has shown an enhanced capacity of chondrocytes
from OA cartilage to produce ECM macromolecules. However, the same cells have increased catabolic signalling pathways. As a
consequence of this increased IL-1 activity and the reduced amounts of IL-1RII decoy receptor, less of the produced ECM macromolecules
may persist in the CAM of the OA chondrocytes.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
Homeostasis of the extracellular matrix (ECM) of articular
cartilage in normal and pathological conditions is depen-
dent on the responses of articular cartilage cells to auto-
and paracrine anabolic and catabolic pathways1,2. Several
studies have highlighted the importance of insulin-like
growth factor 1 (IGF-1) as promoter of growth and matrix
synthesis by articular cartilage cells. IGF-1 has been shown
to enhance the synthesis of aggrecan and type II collagen
by chondrocytes3–6 and to indirectly decrease both the
basal and the cytokine-stimulated degradation of proteogly-
can in cartilage7,8 and was more potent than IGF-2 in the
same batches of articular cartilage when their effects on
biosynthesis and catabolism of proteoglycans were consid-
ered9. Several reports suggest that IGF-1 produced locally
in cartilage may be as physiologically important as the
circulating hormone IGF-210,11.
Both IGFs act through their respective receptors12–14.
IGF-1 interacts with its specific membrane receptor
(IGFR1), which also interacts with IGF-2 and insulin though
with substantially lower affinity. Most of the known effects of
IGF-1 and -2 are mediated by IGFR115. IGF binding
proteins (IGFBP) that are produced by the chondrocytes
and bind to IGF are important controlling factors of IGF
activity16–19. The secretion of IGFBP is controlled by the
cytokines IL-1 and TNF-17.
Turnover and degradation of the matrix is dependent on
the responsiveness of the articular cartilage cell to cata-
bolic cytokines of which IL-1 and  are the main agon-
ists20,21. Besides capability to induce resorption of articular
cartilage, IL-1 has been shown to directly depress the
synthesis of aggrecan and collagen by the chondro-
cyte22,23. In addition, IL-1 may depress chondrocytes by
reducing IGFI access to these cells by enhancing IGFBP
synthesis17,19. The IL-1 effects are mediated through a
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high-affinity cell surface receptor, IL-1RI24,25. The most
important controlling factor of IL-1 activity is the type 2 IL-1
decoy receptor (IL-1RII). IL-1RII is expressed on the
chondrocyte plasma membrane, binds IL-1 and , but
does not transmit the IL-1 signals26,27.
We examined the autocrine/paracrine anabolic/catabolic
pathways that are potentially relevant to ECM homeostasis
in normal and osteoarthritic (OA) femoral condyle cartilage.
We focused on the in vitro accumulation of aggrecan, type
II collagen and of fibronectin in the cell-associated matrix
(CAM) of phenotypically stable chondrocytes obtained from
normal and fibrillated cartilage of knee joints showing focal
OA lesions. Flow cytometry allows the amounts of these
ECM macromolecules in the CAM of isolated articular
cartilage cells to be quantified28,29.
Material and methods
ISOLATION OF CHONDROCYTES
Human articular chondrocytes were isolated as de-
scribed elsewhere30 with a few modifications31. Articular
cartilage was obtained at autopsy from 10 donors (four
males, six females, age range 37–80 years; mean age±1
standard deviation (SD): 63.2±12.6 years) within 24 h post-
mortem. All donors had died after a short illness and had
not been receiving corticosteroids or cytostatic drugs. The
knee joints showing focal OA lesions were used to obtain
visually intact cartilage and OA cartilage. The cartilage
tissue was sampled from the femur condyles, diced into
small fragments and digested in a spinner bottle with a
series of enzymatic solutions in Dulbecco’s modified
Eagle’s medium (DMEM; GIBCO BRL, Grand Island, NY,
USA) with 0.002 M/ml L-glutamine and antibiotics and anti-
mycotics (GIBCO BRL). Cartilage was first treated
with 0.25% (w/v) of sheep testes hyaluronidase (Sigma,
St Louis, MO, USA) for 120 min and 0.25% of pronase
(Streptomyces griseus pronase E; Sigma) for 90 min at
37°C. After an overnight period in DMEM supplemented
with 10% foetal calf serum (FCS; GIBCO BRL), a 3–6 h
incubation with 0.25% collagenase (Clostridium histolyti-
cum; Sigma) in DMEM containing 10% FCS at 37°C
resulted in the liberation of isolated cartilage cells. Depend-
ing on the condition of the tissue, 50–150×106 chondro-
cytes could be obtained from femoral condyles of one
individual and over 95% of the cells were viable (trypan
blue exclusion test) after isolation.
CULTURE OF CHONDROCYTES IN ALGINATE GEL
Chondrocyte cultures in alginate beads were prepared
as described elsewhere32 with some modifications.
Chondrocytes suspended in 1 volume double-concentrated
Hanks’ Balanced Salts Solution without calcium and mag-
nesium (HBSS; Gibco) were carefully mixed with an equal
volume of 4% alginate (low-viscosity alginate from Macro-
cystis pyrifera; Sigma) in HBSS, autoclaved for 15 min. The
final cell concentration was 5×106 chondrocytes per ml in
2% alginate. The chondrocyte/alginate suspension was
then slowly dripped through a 23-gauge needle into a
102 mM calcium chloride solution. The beads were allowed
to polymerise for 10 min at room temperature. The calcium
chloride was then removed, the beads were washed three
times with 0.15 M sodium chloride and finally maintained in
a six-well plate in 4 ml of DMEM with 10% FCS and 50 µg
ascorbate per ml in an incubator at 37°C under 5% CO2.
The chondrocyte cultures consisted of 1×106 cells per
culture (each well containing 20 alginate beads; ±50 000
chondrocytes per bead). The nutrient medium was
replaced twice weekly for 7 days.
PREPARATION OF CHONDROCYTES FOR FLOW CYTOMETRY
After the respective culture periods, the medium of the
cultures was aspirated and the alginate beads were
washed and dissolved by incubation for 10 min with 3 ml of
55 mM tri-sodium citrate dihydrate pH 6.8, 0.15 M NaCl
at 25°C. The resulting suspension was centrifuged at
1500 rpm for 10 min to separate cells with their CAM33 from
the constituents of the interterritorial matrix. IGFR1, IL-1RI
and -II on the cell membrane, and aggrecan, type II
collagen and fibronectin in the CAM were tested directly
after incubation with the appropriate antibodies for 30 min
in the dark at 4°C. Twenty microliters of 50 µg/ml FITC-
labelled antibodies were used to react with 2×105 cells
resuspended in 100 µl PBS. In order to evaluate the
expression of IGF-1, IL-1 and  inside the cells, chondro-
cytes were permeabilized using Cytofix/Cytoperm Plus™
Kit (PharMingen, San Diego, CA, USA) according to the
manufacturer’s instruction. Briefly, cells in culture were
incubated with monensin (GolgiStop™, 4 µl/6 ml medium)
for 5 h to block the protein transport from Golgi apparatus.
The cells were then isolated from alginate and permeabi-
lized using Cytofix/Cytoperm™ solution for 20 min. After a
wash in 1× Perm/Wash™ solution, the procedure was
followed by the incubation with monoclonal antibodies
(Mabs).
ANTIBODIES USED FOR FLOW CYTOMETRY
Mouse anti-human Mabs (subclass IgG1) against IGFR1,
IL-1RI, IL-1RII, IL-1 and the mouse IgG1 negative control
were bought from R&D systems (Abingdon, UK; IGFR1:
clone 33255.111; IL-1RI: clone 35730.111; IL-1RII: clone
34141.11; Il-1: clone 8516.311). Mouse anti-human IGF-1
and IL-1 Mabs were purchased from Biosource Europe
(Nivelles, Belgium; IGF-1: clone AHG0014; IL-1: clone
624B3F2). Polyclonal anti-fibronectin rabbit IgG were from
Chemicon International (Harrow, UK). Mouse anti-human
chondrocyte-specific aggrecan Mab (clone 4D11-2A9, Bio-
source Europe) was shown to react specifically with the
G1-domain of the invariable hyaluronan-binding region of
the human aggrecan molecule, and was used to detect the
aggrecan in the chondrocyte CAM. Mouse anti-human type
II collagen Mab (clone II-4C11, ICN Biochemicals, Ohio,
USA) was chosen to detect type II collagen. All the anti-
bodies (except aggrecan and type II collagen) were conju-
gated with fluorescein isothiocyanate (FITC, Isomer I,
Sigma-Aldrich, Belgium) as previously described28. The
anti-aggrecan and type II collagen Mab were conjugated
with phycoerythrin (PE, Sigma-Aldrich) as described34. The
conjugated Mabs were used in a direct immunofluorescent
staining protocol for flow cytometry. Appropriate FITC- or
PE-labelled isotype matched mouse or rabbit IgG1 (Becton
Dickinson: clone X40) were used as a negative control.
FLOW CYTOMETRIC ANALYSIS
Stained cells were analysed on a flow cytometer (FAC-
Sort, Becton Dickinson, San Jose, CA, USA) with CELL-
Quest software. From each sample, 15 000 events were
analysed. Cells were gated on forward and side scatter to
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exclude cell debris and aggregates. Propidium iodide was
additionally used to exclude dead cells when the epitopes
outside the cells, i.e., IGFR1, IL-1RI and -II and ECM
molecules, were analysed28,29. The mean fluorescence
intensity (MFI) of the positive cell population, which is due
to the binding of the conjugated antibodies to the specific
antigen, was used to quantify the presence of IGFR1,
IL-1RI and -II on the plasma membrane, of the ECM
molecules in the CAM, and the accumulation of IGF-1,
IL-1 and  inside the cells. MFI values were obtained by
subtraction of the MFI of the negative control population
from the MFI of the positive stained population. For com-
parison between experiments Quantum Simply Cellular
Microbead Kit (Sigma) was used to calibrate the fluor-
escence scale of the flow cytometer. The product contains
a mixture of four uniform microbead populations, which
differ by their incremental capacities to bind mouse IgG.
The microbeads were stained and processed in parallel
with the cell samples using the same amount of FITC-
labelled antibodies and incubation time. The fluorescence
scale of the cytometer was adapted before every exper-
iment in order to keep identical MFIs for the four peaks of
the calibration beads. The MFI of cell samples was then
analysed without changing any instrument settings.
STATISTICAL ANALYSIS
Mean values and S.D. of the MFI values were calculated
from triplicate cell cultures. Means and S.D. for the different
variables obtained from the whole donor population were
also presented. The correlations between the mean values
of different parameters in chondrocyte cultures in equilib-
rium were done with the Spearman’s test. Since the clas-
sical Bonferroni correction is not applicable for large
number comparisons, a value of P<0.05 was taken to
indicate statistical significance. Such an approach has
been previously used in other studies of large number
comparisons35. The two-sided t test for paired samples was
used to compare the expression of the respective variables
(mean MFI values) by chondrocytes obtained from affected
and unaffected articular cartilage of the same knee joint.
Significance levels for Student’s t tests were set at
P0.05.
Results
INTRACELLULAR CYTOKINE AND GROWTH FACTOR LEVELS,
EXPRESSION OF THE RESPECTIVE PLASMA MEMBRANE
RECEPTORS, AND HOMEOSTASIS OF CAM MOLECULES IN
ARTICULAR CARTILAGE FROM OA JOINTS
Expression of different antigens on the chondrocytes
from the 10 donors was quantified using chondrocyte MFI
values after staining with the respective specific conjugated
antibodies. The mean and 1 S.D. values of the different
variables obtained in triplicate samples of each donor are
presented in Tables I and II. Average coefficient of variation
(CV) values for each of these variables were calculated
from these data and illustrated the reliability of the tech-
nique (legends of Tables I and II). The MFI values reflect
the number of FITC-conjugated antibodies fixed on the
chondrocytes and—as Mabs were used—the number of
detected epitopes. The MFI values for each of these items
varied widely through the chondrocyte populations.
IGFR1/IGF-1 AUTOCRINE/PARACRINE PATHWAY
When compared with unaffected tissue, chondrocytes
from affected tissues showed significantly increased MFI
values for IGFR1 (normal vs OA: 1.9±1.2 and 3.2±2.1,
P0.004) and IGF-1 (normal vs OA: 41.4±32.3 and
57.1±42.4, P0.010). On average, chondrocytes from de-
generated tissues expressed 64.6±35.1% more IGFR1 and
showed 43.0±16.8% more intracellular IGF-1 (Fig. 1).
IL-1R/IL-1 AUTOCRINE/PARACRINE PATHWAY
Significant increases in MFI values were also observed
for intracellular IL-1 (normal vs OA: 21.5±9.8 and
24.5±9.9, P0.009), IL-1 (normal vs OA: 38.6±20.8 and
51.7±23.8, P0.015), and for plasma membrane IL-1RI
(normal vs OA: 0.86±0.48 and 1.61±0.94, P0.001). When
compared with chondrocytes from visually intact cartilage,
average increases of 17.7±13.3, 39.0±31.9 and
88.5±51.1% were calculated for intracellular IL-1 and ,
and for plasma membrane IL-1RI, respectively (Fig. 1).
Chondrocytes derived from OA sites expressed less
membrane-bound IL-1RII (normal vs OA: 2.33±0.83 and
1.66±0.58, P0.011). An average decrease in IL-1RII of
−32.7±14.4% was seen in OA chondrocytes (Fig. 1).
THE ACCUMULATION OF ECM COMPOUNDS IN THE CAM
Mean chondrocyte MFI values for aggrecan, type II
collagen and fibronectin were found significantly lower in
chondrocytes isolated from degenerated tissue (normal vs
OA—aggrecan, 15.5±9.1 and 9.5±5.9, P0.046; type II
collagen, 4.8±2.8 and 3.3±2.5, P0.014; fibronectin,
324.5±189.9 and 245.3±151.6, P0.006). When compared
with chondrocytes from visually intact cartilage, average
decreases of CAM accumulated aggrecan, type II collagen
and fibronectin amounted to −37.1±18.4, −36.9± 23.2 and
−29.2±11.5%, respectively (Fig. 1).
CORRELATIONS BETWEEN INTRACELLULAR CYTOKINE AND
GROWTH FACTOR LEVELS, EXPRESSED PLASMA MEMBRANE
RECEPTORS AND ACCUMULATED CAM MOLECULES IN ARTICULAR
CARTILAGE TISSUES FROM OA JOINTS
Correlations between the expression of the receptors on
the cell membrane, IGF-1, IL-1 and  levels inside the
cells and the accumulation of CAM molecules are shown in
Tables III and IV.
CAM levels of aggrecan and type II collagen were
correlated in unaffected cartilage-derived chondrocyte cul-
tures (r0.896, P0.006). Aggrecan and fibronectin levels
were related in the CAM of OA cartilage-derived chondro-
cytes (r0.844, P0.017). In cell cultures obtained from
unaffected cartilage a correlation was observed between
the functional IL-1RI on the plasma membrane and the
intracellular IL-1 levels. A correlation between the two
isoforms of IL-1 was obvious in both affected and unaf-
fected tissue-derived cultures (visually intact cartilage: r
0.762, P0.028; OA cartilage: r0.692, P0.057). IGFR1,
but not IGF, significantly correlated with CAM fibronectin in
both affected and unaffected tissue-derived cultures (intact
cartilage: r0.761, P0.011; OA cartilage: r0.826, P
0.003). Furthermore, there was a significant correlation
between membrane-bound IGFR1 and CAM type II colla-
gen in OA tissue-derived chondrocyte cultures (r0.754,
P0.050). In none of the cultures, levels of CAM ECM
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Table I
MFI values for growth factors and cytokines, their receptors and CAM compounds of chondrocytes from macroscopically intact cartilage
Sex/age IGFRI IGF-1 IL-1RI IL-1RII IL-1 IL-1 COLL II AGGR FNECT
F72 5.00 ± 0.47 0.70 ± 0.07 3.78 ± 0.28 709.8 ± 11.6
F65 2.78 ± 0.36 0.35 ± 0.04 1.48 ± 0.03 550.9 ± 9.8
F80 0.99 ± 0.12 13.25 ± 2.64 0.26 ± 0.03 2.13 ± 0.17 20.16 ± 2.49 28.50 ± 2.69 4.24 ± 0.15 22.12 ± 0.82 426.6 ± 39.9
F55 1.88 ± 0.13 23.32 ± 2.40 0.65 ± 0.05 2.21 ± 0.15 26.18 ± 3.81 34.13 ± 1.68 217.1 ± 12.4
F37 1.37 ± 0.13 28.88 ± 1.49 0.99 ± 0.08 3.36 ± 0.14 22.37 ± 1.67 39.49 ± 4.09 9.50 ± 1.38 28.04 ± 3.72 239.3 ± 26.8
M60 1.22 ± 0.28 100.40 ± 7.80 0.82 ± 0.07 1.93 ± 0.39 14.70 ± 1.65 49.67 ± 0.82 7.49 ± 1.20 22.28 ± 3.31 361.0 ± 28.7
M63 1.71 ± 0.09 11.02 ± 1.50 1.79 ± 0.22 3.17 ± 0.22 32.18 ± 0.54 75.09 ± 2.16 4.20 ± 0.12 9.83 ± 0.34 155.2 ± 6.5
M80 1.86 ± 0.33 41.24 ± 2.66 1.35 ± 0.30 1.78 ± 0.17 36.19 ± 0.95 52.01 ± 2.03 4.20 ± 0.41 15.09 ± 1.41 292.2 ± 3.7
M62 1.51 ± 0.21 80.40 ± 2.59 1.23 ± 0.16 2.38 ± 0.22 12.92 ± 1.14 24.27 ± 1.74 2.58 ± 0.07 8.39 ± 0.49 223.2 ± 15.7
F58 1.14 ± 0.13 32.28 ± 1.08 0.48 ± 0.02 1.77 ± 0.22 7.38 ± 0.12 6.05 ± 0.73 1.44 ± 0.16 2.45 ± 0.35 130.2 ± 4.0
Mean±S.D. 1.95 ± 1.18 41.30 ± 32.30 0.86 ± 0.48 2.33 ± 0.83 21.50 ± 9.81 38.60 ± 20.8 4.80 ± 2.79 15.50 ± 9.13 320.47 ± 200.9
MFI, mean fluorescence intensity value; CAM, cell-associated matrix; COLL II, type II collagen; AGGR, aggrecan; FNECT, fibronectin; mean±1 S.D. for all individual experiments in triplicate
are given in the table; bottom line, mean±1 S.D. for all chondrocyte cultures. CV, average coefficients of variation (1 S.D.100/mean) for the respective variables were calculated from the
data in the table: IGFRI, 12.21%; IGF-1, 8.71%; IL-1RI, 10.90%; IL-1RII, 8.36%; IL-1, 7.54%; IL-1, 6.55; aggrecan, 9.25%; type II collagen, 8.65%; fibronectin, 6.89%.
Table II
MFI values for growth factors and cytokines, their receptors and CAM compounds of chondrocytes from degenerated cartilage
Sex/age IGFRI IGF-1 IL-1RI IL-1RII IL-1 IL-1 COLL II AGGR FNECT
F72 8.53 ± 0.38 1.40 ± 0.10 1.89 ± 0.13 528.0 ± 28.7
F65 5.15 ± 0.40 0.66 ± 0.04 1.02 ± 0.05 462.3 ± 26.6
F80 1.79 ± 0.14 20.38 ± 2.64 0.41 ± 0.02 1.60 ± 0.01 26.50 ± 1.88 45.43 ± 2.91 2.09 ± 0.34 18.90 ± 0.82 356.0 ± 22.9
F55 2.24 ± 0.19 33.35 ± 3.65 1.52 ± 0.06 1.83 ± 0.14 26.68 ± 3.10 43.07 ± 0.86 156.8 ± 33.6
F37 2.80 ± 0.18 46.18 ± 4.00 1.41 ± 0.06 2.28 ± 0.17 24.42 ± 1.39 78.12 ± 2.01 5.88 ± 0.15 8.68 ± 0.42 120.2 ± 9.9
M60 2.73 ± 0.20 120.50 ± 13.7 1.06 ± 0.08 0.88 ± 0.07 16.75 ± 1.13 59.54 ± 3.20 7.23 ± 1.10 15.18 ± 1.26 186.3 ± 16.2
M63 2.01 ± 0.13 17.33 ± 0.91 3.70 ± 0.28 2.43 ± 0.15 38.82 ± 1.14 83.00 ± 2.00 3.28 ± 0.25 6.82 ± 0.16 107.1 ± 3.7
M80 2.64 ± 0.28 56.69 ± 1.51 2.33 ± 0.10 1.50 ± 0.17 36.47 ± 1.12 56.56 ± 1.30 3.43 ± 0.20 9.64 ± 0.45 210.0 ± 22.6
M62 2.39 ± 0.03 124.60 ± 17.8 2.18 ± 0.18 1.76 ± 0.07 16.64 ± 0.86 40.30 ± 1.20 0.98 ± 0.12 6.38 ± 0.34 165.4 ± 12.6
F58 1.64 ± 0.09 37.79 ± 1.15 1.47 ± 0.15 0.85 ± 0.14 9.97 ± 0.25 7.46 ± 0.20 0.52 ± 0.09 1.14 ± 0.16 100.7 ± 4.0
Mean±S.D. 3.23 ± 2.16 57.10 ± 42.40 1.61 ± 0.94 1.66 ± 0.58 24.50 ± 9.93 47.21 ± 21.77 3.34 ± 2.47 9.50 ± 5.89 254.3 ±151.6
P value 0.0038 0.0099 0.0013 0.011 0.0093 0.025 0.0141 0.0461 0.014
MFI, mean fluorescence intensity value; CAM, cell-associated matrix; COLL II, type II collagen; AGGR, aggrecan; FNECT, fibronectin; mean±1 S.D. for all individual experiments in triplicate
are given in the table; mean±1 S.D. for all chondrocyte cultures are also given. CV, average coefficients of variation (1 S.D.100/mean) for the respective variables were calculated from the
data in the table: IFGRI, 6.61%; IGF-1, 8.65%; IL-1RI, 6.42%; IL-1RII, 8.08%; IL-1, 5.60%; IL-1, 3.34; aggrecan, 6.27%; type II collagen, 11.01%; fibronectin, 6.61%. P value, comparison
of visually intact (Table I) and OA cartilage (given in the table) from the same joint.
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molecules did correlate with the agonists of the IL-1
pathway.
Discussion
The objective of these studies was to search for differ-
ences in the autocrine/paracrine pathways directing the
homeostasis of the ECM in chondrocytes from normal and
degenerated articular cartilage from OA joints.
Exclusively knees showing partial thickness chondral
damage with fragmentation of the surface were selected.
The removal in the mortuary room of articular cartilage from
subjects without radiological documentation rendered
the investigators unable to document any subchondral
bony changes and to grade the morbidity of the OA. Our
observations thus strictly relate to visually intact and
degenerated cartilage from the knee joint.
Many of the postmortem events in human knee and
ankle joints that were described as typical of OA, such as
minimal to overt fibrillation, localized incomplete defects
and full-thickness cartilage loss with bone exposure, have
been attributed to ‘aging’ rather than to OA36–38. The strong
correlation between increasing age and the prevalence of
OA, and evidence of important age-related changes in the
function of chondrocytes, suggest that these age-related
changes in articular cartilage can contribute to the devel-
opment and progression of osteoarthritis. Changes in cell
metabolism and the alterations in the biochemical compo-
sition of articular cartilage associated with age precede
frank histologic changes in the articular surface and play a
role in the early phases of spontaneously occurring OA in
guinea pig knees and ankles39–41, in mouse knees42 and
mandible joints43. In experimentally induced OA, biochemi-
cal alterations precede cartilage surface lesions that ulti-
mately proceed to obvious OA of the joint44–47. Finally, a
number of investigators who observed similar chondral
damage with degenerative changes at arthroscopy, found a
correlation between osteoarthrosis as seen on arthroscopy
and on the radiographs48,49. It is generally accepted that
focal chondral or osteochondral defects that have a poor
capacity for repair, not only predispose patients to OA, but
also are an element of the OA condition. The factors
underlying this poor capacity for repair are at present not
known. Cartilage superficial cell layers have been in part
lost in OA tissues and new chondrocyte populations with
different phenotypes have replaced these cells to some
degree. It appears essential to distinguish the metabolical
differences and the size of the dissimilarities between the
original and the OA cells, before an attempt can be made to
uncover the causes of these abnormalities.
Our experiments have been conducted on human articu-
lar cartilage chondrocytes that were cultured in alginate.
Although recent gene expression data have shown that
chondrocytes in alginate do not completely regain the
original in vivo molecular phenotype, the complete loss of
differentiation markers may be prevented or delayed in this
artificial matrix50. Therefore, the alginate matrix has been
considered most suitable to culture phenotypically stable
chondrocytes. Topographically dependent phenotypic ex-
pression of ECM compounds in joints, as well as the
age-related decline in the chondrocyte response to growth
factors were preserved when the chondrocytes were cul-
tured in alginate beads51,52. As far as chondrocytes from
intact tissues serve as an internal control for the OA cells,
studies on chondrocytes cultured in vitro in alginate beads
allow valid conclusions to be drawn with respect to
chondrocyte metabolism in degenerated cartilage.
We focused on the accumulation of aggrecan, type II
collagen and of fibronectin in the CAM of these chondro-
cytes. Flow cytometry allowed the amounts of these ECM
macromolecules in the CAM of the isolated articular carti-
lage cells to be quantified, as well as the levels of growth
factors and cytokines inside the cells and the expression of
the respective plasma membrane-bound receptors. As pre-
viously shown, chondrocytes recovered from the isolation
procedure to restore their repertoire of plasma membrane
receptor proteins and to rebuild a cell-associated ECM.
New metabolical steady state conditions were reached
after 1–2 weeks in culture8 and it was thus decided to
perform the investigations after a 1-week culture period.
The reproducibility and reliability of the flow cytometry
technique when applied on intracellular, membrane-
associated and CAM macromolecules of chondrocytes
isolated from hydrogel matrices have been dealt with
previously8,28,29.
Amongst other growth actors, both isoforms of IGF have
been shown to enhance the production of ECM by chondro-
cytes in different in vitro culture systems53,54 and in tissue-
cultured normal and diseased cartilage3–6. Recently, the
accumulation of aggrecan and type II collagen in the CAM
of chondrocytes cultured in alginate has been used to
explore the mechanisms whereby IGF affects synthesis
and turnover of the ECM8. The experiments were con-
ducted on chondrocytes obtained from intact cartilage from
normal knee joints. It was shown that the amount of ECM
compounds in the CAM of these healthy chondrocytes
significantly correlated with the strength of the IGF/IGFR
Fig. 1. Comparison of chondrocytes from degenerated and normal
cartilage. Percentage differences in Mean Fluorescence Intensity
(MFI) for IGFRI, IGF-1, IL-1RI, IL-1 and , IL-1RII, aggrecan
(AGGR), type II collagen (COLL) and fibronectin (FNECT). Dots
represent percentage differences in MFI between normal and
OA chondrocytes as measured in the cells of each individual. Bars
and represent average differences±1 S.D.
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Table III
Chondrocytes from macroscopically intact cartilage from OA knee joints
IGFRI IGFI IL-1RI IL-1RII IL-1 IL-1 COLL II AGGR FNECT
IGFRI –
IGFI −0.134; P0.751 –
IL-1RI −0.095; P0.795 0.056; P0.896 –
IL-1RII 0.471; P0.169 −0.342; P0.407 0.369; P0.294 –
IL-1 0.727; P=0.041 0.448; P0.266 0.569; P0.141 0.280; P0.503 –
IL-1 0.498; P0.210 0.078; P0.855 0.746; P=0.034 0.450; P0.264 0.762; P=0.028 –
COLL II −0.044; P0.926 0.137; P0.769 0.050; P0.916 0.499; P0.254 0.218; P0.639 0.404; P0.369 –
AGGR −0.213; P0.670 0.038; P0.934 −0.199; P0.669 0.315; P0.492 0.236; P0.610 0.273; P0.554 0.896; P=0.006 –
FNECT 0.761; P0.011 0.231; P0.582 −0.455; P0.186 0.180; P0.619 0.054; P0.898 0.066; P0.876 0.359; P0.429 0.694; P0.083 –
Correlations between IGFRI, IL-1RI and -II expression on the cell membrane, IGF-1, IL-1 and  inside the cells, and ECM molecules located in the CAM.
Values are the correlation coefficients (r). P values with significant levels are given in bold. COLL II, type II collagen; AGGR, aggrecan; FNECT, fibronectin.
Table IV
Chondrocytes from degenerated cartilage from OA knee joints
IGFRI IGFI IL-1RI IL-1RII IL-1 IL-1 COLL II AGGR FNECT
IGFRI –
IGFI 0.551; P0.152 –
IL-1RI −0.223; P0.537 −0.098; P0.818 –
IL-1RII −0.035; P0.923 −0.389; P0.341 0.554; P0.097 –
IL-1 0.141; P0.739 −0.489; P0.219 0.549; P0.158 0.660; P0.075 –
IL-1 0.563; P0.146 −0.073; P0.863 0.409; P0.314 0.708; P0.052 0.692; P=0.057 –
COLL II 0.754; P=0.050 0.245; P0.596 −0.137; P0.769 −0.066; P0.888 0.170; P0.716 0.678; P0.094 –
AGGR 0.198; P0.670 0.051; P0.913 −0.543; P0.208 0.052; P0.913 0.223; P0.631 0.318; P0.487 0.451; P0310 –
FNECT 0.826; P0.032 −0.058; P0.891 −0.515; P0.127 −0.160; P0.660 0.147; P0.729 −0.065; P0.878 −0.062; P0.894 0.844; P=0.017 –
Correlations between IGFRI, IL-1RI and -II expression on the cell membrane, IGF-1, IL-1 and  inside the cells, and ECM molecules located in the CAM.
Values are the correlation coefficients (r). P values with significant levels are given in bold. COLL II, type II collagen; AGGR, aggrecan; FNECT, fibronectin.
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pathway, but not with the levels of the IL-1/IL-1RI pathway.
Additional experiments demonstrated that IGF-1 upregu-
lated IL-1RII thereby overruling the catabolic effects of
IL-18. IL-1RII binds IL-1, and to a much lesser extent
IL-1, without participating in their signalling55,56.
The most striking difference between chondrocytes ob-
tained from normal and OA knee joints was the loss of the
IGFR1/IGF-1-orchestrated accumulation of cell-associated
ECM compounds8. In contrast with our earlier observations
on chondrocytes from unaffected knee joints8, no signifi-
cant correlations were found between the main actors of
the anabolic pathways after 1 week in culture. Coordinated
production and accumulation of the different CAM com-
pounds under the effect of the IGFR1/IGF-1 autocrine
pathway was not obvious anymore when the chondrocytes
had been obtained from OA joints. Merely, there was a
significant correlation between membrane-bound IGFRI
and CAM type II collagen in OA tissue-derived chondrocyte
cultures. CAM aggrecan and type II collagen levels were
correlated in unaffected cartilage-derived chondrocyte cul-
tures but not in the cultures derived from degenerated
tissue. The lack of correlation between the activity of the
IGFRI/IGF-1 pathway and the accumulation of the CAM
was obvious in both affected and non-affected tissue-
derived cultures. Although it has to be admitted that there
may be many other pathways, which could be involved in
the regulation of the ECM over and above those that were
explored in the actual study, our findings suggest a more
widespread metabolic disorder in the entire cartilage of the
OA knee joint.
Although chondrocytes from degenerated tissues—when
compared with those from unaffected tissues from OA
joints—showed a significantly increased expression of
IGFR1 and IGF-1, equally significant increases of intra-
cellular IL-1, IL-1, and of plasma membrane IL-1RI were
observed in these cartilage cells. On the other hand,
chondrocytes derived from degenerated tissue of OA joints
expressed less membrane-bound IL-1RII than the cells that
were isolated from unaffected cartilage of the same knee. It
was anticipated that IL-1-activity around chondrocytes from
degenerated tissue was not neutralized by IL-1RII and,
therefore, mean chondrocyte MFI values for CAM aggre-
can, type II collagen and fibronectin significantly decreased
in these cells.
Others have reported the up-regulation of both cata-
bolic1,2 and anabolic1,2,57–59 pathways in OA chondrocytes
or cartilage. A correlation with the occurrence and the
degree of OA pathology was noted for IL-11,2,60 and these
elevated catabolic cytokine levels are embodied by well-
documented increases in metalloprotease activities, which
were higher in OA cartilage compared with morphologically
normal cartilage from the same joint60–63. In addition, an
increase in IL-1RI receptor density was found in OA
chondrocytes as compared with normal chondrocytes. As a
consequence of the increased IL-1RI density, the IL-1
concentration required for half-maximal metalloprotease
stimulation was several times lower in OA chondrocytes
than in normal cells64.
IL-1 in particular could be implicated in the up-
regulation of the IGFR1/IGF-1 autocrine/paracrine axis in
OA chondrocytes65. IGF-1 and IGFR1 mRNA and protein
levels were significantly higher in fibrillated OA cartilage,
than in non-fibrillated cartilage of OA hip joints58,59. The
strongest IGF-1 message signals or protein levels were
observed in chondrocytes of more advanced lesions58,59.
The data presented here strongly advocate the role of
the plasma membrane receptors as the factors controlling
the effects of the respective ligands. Since Mabs were used
for all the epitopes studied, it was assumed that equimolar
amounts of Mabs reacted with the target molecules. MFI
values thus correlated with the amount of the plasma
membrane-bound receptors and their ligands. The low MFI
values for plasma membrane receptor IGFR1, IL-1RI and
-II levels reflected the presence of merely a few thousands
of these molecules on a chondrocyte in normal tissues66,67.
Similar low values have been presented when chondrocyte
populations obtained from intact joints were analysed. The
flow cytometry method was proven to be accurate enough
to detect significant changes when these cells were ex-
posed to biological stimuli8. MFI values of intracellular
growth factors and cytokines, which represent a reservoir
of biologically active agents that can be secreted as a
consequence of various metabolical stimuli, were found to
outnumber the MFI values of their respective plasma mem-
brane receptors by a factor of 10. The relation between the
accumulation and maintenance of the ECM compounds in
the CAM, and the activity of the IGF-1/IGFRI pathway has
been illustrated recently8. In the presence of an abundant
amount of IL-1, it can be reasonably assumed that the
dimly expressed IL-1RI and -II will decide for the effects of
the catabolic pathways. Especially the ratio between both
receptors will be critical for accumulation or release of ECM
compounds in the CAM. With respect to this IL-1RI/-II ratio,
our finding of decreased plasma membrane levels of IL-
1RII in chondrocytes from OA tissues is of significance.
IGF-1-induced IL-1RII on chondrocytes was found to re-
press IL-1 activities and to control the homeostasis of
healthy human articular cartilage8. This quotation lays
emphasis on chondrocyte IL-1RI and -II as important
targets in the therapy of OA.
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